For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of Tafamidis and the formulated version represents a significant change. These innovative therapies protect the transthyretin protein, slowing its harmful build-up and alleviating the impact of the condition . People are now experienci… Read More